Lv11
26 积分 2026-04-07 加入
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Emergency Complex Higher-risk and Indicated Patients
33分钟前
已完结
Eficacia y seguridad de los inhibidores de la PCSK9 en la vida real
2小时前
已关闭
Effectiveness and safety of long‐term therapy with alirocumab in acute coronary syndrome patients: A single‐centre retrospective real‐world study
2小时前
已完结
Inclisiran Therapy and Lipid Profile Dynamics in Real-World Clinical Practice in Russia: Interim Results of an Observational Study
2小时前
已完结
皖公网安备34019202002308
